EFTA01197764Set 9
8p3,954w
number of siRNA drugs and uses Tekmkira's LNP delivery patents.
• Opko Health (OPK US) - the Company is involved in the discovery, development, and
commercialization of pharmaceuticals products, vaccines ... early stage) $505.07
AI nylam Pharma ALNY US $63.97 $4,088.8 $63.97
Opko Health OPK US $9.08 $3,652.0 $9.08
Isis Pharma ISIS Us $42.90 $4,873.8 $42.90
Avg RNAi
https://www.justice.gov/epstein/files/DataSet%209/EFTA01197764.pdf
EFTA02714282Set 11
8p3,952w
number of siRNA drugs and uses Tekmkira's LNP delivery patents.
• Opko Health (OPK US) — the Company is involved in the discovery, development, and
commercialization of pharmaceuticals products, vaccines ... RNAI (early stage) $505.07
Alnylam Pharma MIN US $63.97 $4,088.8 $63.97
Opko Health OPK US $9.08 $3,652.0 $9.08
Isis Pharma ISIS US $42.90 $4,873.8 $42.90
Avg RNAI
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02714282.pdf
EFTA02092911Set 10
2014-10-168p2,182w
ARCP, CAK, CERU, CNAT, CNCE, CUDA, GME, GPT, HPQ, INFI,
MCS, MRTX, NMBL, OMN, OPK, PTX, RGEN, SYRX
EFTA_R1_00692855
EFTA02092914
Shareholder Meetings: ACM, LQMT, URS, PPHM
Other Newspaper
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02092911.pdf
EFTA00411369Set 9
5p1,719w
SLXP, SUMR, VNDA, ALIM,
CHDN, DLTR, FCX, INAP, LMAT, LSE, MOV, OPK, SBGI, SCVL, TSYS, CBOE, CLVS, BCPC, CLR, CLWR,
DSS, DUSA, GMO, REFR, SPRO, VC, KW, LNKD, MELI, NWPX
https://www.justice.gov/epstein/files/DataSet%209/EFTA00411369.pdf
EFTA00406719Set 9
2012-08-146p1,737w
FLIR, G, HBI, HLSS,
HME, IP, KSU, MAS, MCP, MRX, NEON, NVE, OCN, OPK, RAX, RTN, TMS, UFCS, WEC, OMER, LXRX
Shareholder Meetings: NAVB, SPEX, ARG, CRWS, KID, AMCC, CAAS
https://www.justice.gov/epstein/files/DataSet%209/EFTA00406719.pdf
EFTA02447858Set 11
2016-10-232p441w
October 23, 2016 3:25 PM
To: Larry Visoski
Subject: Re: new schedule
all opk
On Sun, Oct 23, 2016 at 11:23 AM, Larry Visoski < > wrote:
Schedule received,.thank
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02447858.pdf